If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrasers Group Regulatory News (FRAS)

Share Price Information for Frasers Group (FRAS)

Share Price is delayed by 15 minutes
Get Live Data
730.50    -18.00 (-2.40%)
Bid:
731.00
Ask:
732.50
Spread: 1.50 (0.205%)
Market Cap: £3.14b
FRAS Live PriceLast checked at - London Stock Exchange

Intraday Frasers Group Share Chart

Director/PDMR Shareholding

24 Dec 2025 07:00

RNS Number : 7268M
Frasers Group PLC
24 December 2025
 

Date: 24 December 2025

 

FRASERS GROUP PLC

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

Frasers Group plc (the "Company") announces that on 23 December 2025 the four existing awards ("Awards") held under the Company's Executive Share Scheme (the "ESS") over ordinary shares of nominal value 10p each in the Company ("Shares") were amended to the revised number of Shares as shown in the table below:

 

Name of PDMR

Position

Revised number of Shares subject to Award

Michael Murray

Chief Executive Officer

8,403,361

Chris Wootton

Chief Financial Officer

833,333

Sean Nevitt

Chief Supply Chain Officer

833,333

David Al-Mudallal

Chief Operating Officer

2,100,840

 

The amendments were made pursuant to the updated rules of the ESS approved by shareholders at the Annual General Meeting of the Company held on 24 September 2025.

 

Further detail as to the terms of the amended Awards, updated ESS and related rationale is as set out in the aforementioned notice of Annual General Meeting.

 

The following notifications are made in accordance with the requirements of the UK Market Abuse Regulation.

 

 

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

1. Michael Murray

2. Chris Wootton

3. Sean Nevitt

4. David Al-Mudallal 

2.

Reason for the notification

a)

Position / status

1. Chief Executive Officer

2. Chief Financial Officer

3. Chief Supply Chain Officer

4. Chief Operating Officer 

b)

Initial notification /

Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frasers Group plc

b)

LEI

213800JEGHHEAXIJDX34

4.

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

 

Identification Code

Ordinary shares of 10p each

 

 

 

GB00B1QH8P22

b)

Nature of the transaction

1. Amendment to an existing award held under the Company's Executive Share Scheme.

2. Amendment to an existing award held under the Company's Executive Share Scheme.

3. Amendment to an existing award held under the Company's Executive Share Scheme.

4. Amendment to an existing award held under the Company's Executive Share Scheme.

 

In each case the amendments included increasing the number of ordinary shares comprised with the existing awards to the revised numbers disclosed below. In each case the amended awards are subject to the updated rules of the Executive Share Scheme approved by shareholders at the Annual General Meeting of the Company held on 24 September 2025.

c)

Price(s) and volume(s)

 

PDMR

Price(s)

Volume(s)

1.

£ Nil

8,403,361

2.

£ Nil

833,333

3.

£ Nil

833,333

4.

£ Nil

2,100,840

d)

Aggregated information

Aggregated volume

 

 

 

Price

 

N/A each a single transaction

 

 

 

Nil

 

e)

Date of the transaction

23 December 2025

f)

Place of the transaction

Outside a trading venue

 

 

- END -

 

FRASERS GROUP PLC  

 

Chris Wootton, Chief Financial Officer

T. 0344 245 9200 

E. Financial@frasers.group

 

Andrew Kasoulis, Investor Relations Director

T. 07826 532191 

E. Andrew.Kasoulis@frasers.group

 

Emma Reid, Company Secretary 

LEI: 213800JEGHHEAXIJDX34 

T. 0344 245 9200 

E. company.secretary@frasers.group 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFEWFWDEISEEE
Date   Source Headline
25th Oct 20232:30 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSNotification of Major Holdings
25th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares
23rd Oct 20237:00 amRNSTransaction in Own Shares
20th Oct 20237:00 amRNSTransaction in Own Shares
19th Oct 20231:01 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSTransaction in Own Shares
18th Oct 20237:00 amRNSTransaction in Own Shares
18th Oct 20237:00 amRNSRule 19.6(c) take over code update
17th Oct 20237:00 amRNSBusiness acquisition
17th Oct 20237:00 amRNSTransaction in Own Shares
16th Oct 202311:26 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSNotification of Major Holdings
16th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20232:04 pmRNSHolding(s) in Company
6th Oct 20233:16 pmRNSHolding(s) in Company
6th Oct 20238:24 amRNSNotification of Major Holdings
6th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
2nd Oct 20237:00 amRNSTotal Voting Rights
29th Sep 20237:00 amRNSTransaction in Own Shares
28th Sep 20233:19 pmRNSHolding(s) in Company
28th Sep 202310:55 amRNSHolding(s) in Company
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20234:24 pmRNSResponse to Press Coverage
21st Sep 202310:45 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSShare Buyback Programme
20th Sep 20234:00 pmRNSResult of AGM
20th Sep 202310:31 amRNSHolding(s) in Company
20th Sep 202310:29 amRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 202311:34 amRNSHolding(s) in Company
19th Sep 202310:35 amRNSHolding(s) in Company
19th Sep 20239:54 amRNSHolding(s) in Company
19th Sep 20239:43 amRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares
15th Sep 20237:00 amRNSTransaction in Own Shares
14th Sep 20237:00 amRNSTransaction in Own Shares
12th Sep 20237:00 amRNSTransaction in Own Shares
11th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 202310:35 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.